Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
107 hedge funds and large institutions have $204M invested in Aratana Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 30 closing their positions.
16% less funds holding
Funds holding: 128 → 107 (-21)
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
23% less capital invested
Capital invested by funds: $265M → $204M (-$60.4M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
63% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 30
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $134K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$6.51M |
| 2 |
BC
Broadfin Capital
New York
|
+$4.93M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.54M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.47M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.67M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.57M |
| 3 |
HHC
Hutchin Hill Capital
New York
|
-$1.23M |
| 4 |
Millennium Management
New York
|
-$1.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GAM
126
Gotham Asset Management
New York
| – | -$112K | -12,017 | Closed |
|
127
Two Sigma Advisers
New York
| – | -$108K | -11,500 | Closed |
|
|
BG
128
BlackRock Group
London,
United Kingdom
| – | -$59K | -6,294 | Closed |
|
|
EWM
129
Evercore Wealth Management
New York
| – | -$44K | -4,702 | Closed |
|
|
QT
130
Quantbot Technologies
New York
| – | -$40K | -4,301 | Closed |
|
|
CG
131
Cutler Group
San Francisco,
California
| – | -$14.9K | -1,839 | Closed |
|
|
PCM
132
Prelude Capital Management
New York
| – | -$17K | -1,800 | Closed |
|
133
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$7K | -713 | Closed |
|
134
Group One Trading
Chicago,
Illinois
| – | -$4.61K | -570 | Closed |
|
|
NFG
135
Next Financial Group
Houston,
Texas
| – | -$3K | -350 | Closed |
|
136
Creative Planning
Overland Park,
Kansas
| – | -$2K | -170 | Closed |
|
PETX Hedge Fund Activity: Q4 2016 in Review
107 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q4 2016, worth a combined $204M — down 23% from $265M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PETX and 11 opened new positions — a net loss of 19 holders — while 40 trimmed existing stakes and 33 added.
The largest buyer was Janus Henderson Investors US, adding an estimated $6.51M. The largest seller was Acadian Asset Management, cutting an estimated $5.67M.
- 107 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q4 2016, down from 128 in Q3 2016.
- Funds reported $204M of Aratana Therapeutics, Inc. stock for Q4 2016, down 23% quarter-over-quarter.
- 11 funds opened new Aratana Therapeutics, Inc. positions in Q4 2016 and 30 closed out, a net change of -19 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q4 2016 was Janus Henderson Investors US, an estimated $6.51M added.
- The largest Aratana Therapeutics, Inc. seller in Q4 2016 was Acadian Asset Management, an estimated $5.67M sold.
Based on aggregated 13F filings for Q4 2016.